Vaccine for Lung Cancer Shows Promise in Study

An experimental vaccine wiped out lung cancer in some patients and slowed its spread in others in a small but promising study, researchers from the Baylor University Medical Center in Dallas reported Wednesday in the Journal of the National Cancer Institute. Three patients injected with the vaccine, GVAX, had no recurrence of lung cancer for more than three years afterward, according to the study of 43 people with the most common form of the disease, non-small cell lung cancer.

Non-small cell lung cancer is the nation's leading cause of cancer death, killing more than 150,000 people each year.